PNTGThe Pennant Group, Inc.Healthcare · Medical - Care Facilitiesas of 2026-09-16
Horizon

Issued 2026-09-16 at $42.48 · now $42.48 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, PNTG has typically landed between $33.51 and $52.22 — a range of −21.1% to +22.9% from the issuance price $42.48.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

1,728 overlapping 1 month windows · 2019-10-01 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($42.48) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where PNTG has typically landed a month from the 2026-09-16 close of $42.48 — the range is history, not a prediction.

$33.51worst · -21.1%$52.22best · +22.9%
  • now $42.48 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $43.27 (+1.9%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $39.71–$46.84
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $33.51–$52.22
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 1,728 windows spanning 2019-10-01 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2020-02-18−67.0%−67.0%+4.0%
2020-02-13−61.0%−61.0%+0.0%
2020-02-19−59.7%−67.8%+1.3%
3 best
2020-07-20+89.2%+0.0%+89.2%
2020-07-17+89.0%+0.0%+89.0%
2020-03-18+88.7%+0.0%+88.7%

1,728 overlapping windows · 2019-10-01 – 2026-09-16 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~7 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
29%
−4.6%
n=7
Feb
57%
+6.7%
n=7
Mar
43%
−6.5%
n=7
Apr
57%
+3.5%
n=7
May
71%
+7.3%
n=7
Jun
57%
−1.8%
n=7
Jul
57%
+0.6%
n=7
Aug
71%
+10.5%
n=7
Sep
57%
−2.8%
n=7
Oct
33%
+0.4%
n=6
Nov
57%
+7.3%
n=7
Dec
86%
+9.1%
n=7

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$42$242026-08-06: 3 insider sales, $272K — Guerisoli Brent, Steik Jason Paul, Cheney Kirk Sterling2026-07-10: 1 insider sale, $131K — Guerisoli Brent2026-07-07: 1 insider sale, $128K — Guerisoli Brent2026-05-22: 4 insider sales, $158K — Guerisoli Brent …2026-05: 4 open-market sales, $158K2026-07: 2 open-market sales, $260K2026-08: 3 open-market sales, $272K↑ buys↓ salesofficer Guerisoli Brent — Sale on 2026-08-06, filed 4 days after the tradeofficer Steik Jason Paul — Sale on 2026-08-06, filed 4 days after the tradeofficer Cheney Kirk Sterling — Sale on 2026-08-06, filed 4 days after the tradeofficer Guerisoli Brent — Sale on 2026-07-10, filed 4 days after the tradeofficer Guerisoli Brent — Sale on 2026-07-07, filed 2 days after the tradeofficer Guerisoli Brent — Sale on 2026-05-22, filed 5 days after the tradeofficer Guerisoli Brent — Sale on 2026-05-22, filed 5 days after the tradeofficer Guerisoli Brent — Sale on 2026-05-22, filed 5 days after the tradeofficer Guerisoli Brent — Sale on 2026-05-22, filed 5 days after the trade
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2026-08-06Guerisoli BrentofficerSale4,285 @ $38.52$165K−4.1% of holding−2.9%not yet — horizon still open99,544Form 4 · filed 4 days after the trade
2026-08-06Steik Jason PaulofficerSale1,394 @ $38.52$54K−8.4% of holding−2.9%not yet — horizon still open15,106Form 4 · filed 4 days after the trade
2026-08-06Cheney Kirk SterlingofficerSale1,393 @ $38.52$54K−7.0% of holding−2.9%not yet — horizon still open18,401Form 4 · filed 4 days after the trade
2026-07-10Guerisoli BrentofficerSale3,159 @ $41.56$131K−3.0% of holding−4.5%not yet — horizon still open103,829Form 4 · filed 4 days after the trade
2026-07-07Guerisoli BrentofficerSale3,165 @ $40.51$128K−3.0% of holding−5.2%not yet — horizon still open100,740Form 4 · filed 2 days after the trade
2026-05-22Guerisoli BrentofficerSale2,254 @ $35.08$79K−2.3% of holding+3.4%not yet — horizon still open97,656Form 4 · filed 5 days after the trade
2026-05-22Guerisoli BrentofficerSale2,032 @ $35.08$71K−2.1% of holding+3.4%not yet — horizon still open95,647Form 4 · filed 5 days after the trade
2026-05-22Guerisoli BrentofficerSale200 @ $35.10$7K−0.2% of holding+3.4%not yet — horizon still open95,447Form 4 · filed 5 days after the trade
2026-05-22Guerisoli BrentofficerSale22 @ $34.86$767−0.0% of holding+3.4%not yet — horizon still open97,679Form 4 · filed 5 days after the trade
2025-07-28Guerisoli BrentofficerSale3,995 @ $23.34$93K−4.6% of holding+3.2%+9.2%81,978Form 4 · filed 3 days after the trade
2025-07-28Cheney Kirk SterlingofficerSale880 @ $23.34$21K−6.3% of holding+3.2%+9.2%13,120Form 4 · filed 10 days after the trade
2025-05-20Stringfield JoAnnedirectorSale5,000 @ $29.47$147K−14.2% of holding−6.1%−23.3%30,275Form 4 · filed 3 days after the trade
2025-05-01Stringfield JoAnnedirectorSale665 @ $25.62$17K−2.1% of holding+7.3%−25.6%30,275Form 4 · filed 4 days after the trade
2025-01-30Stringfield JoAnnedirectorSale665 @ $27.88$19K−2.2% of holding−14.5%−23.1%29,040Form 4 · filed 4 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

82 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-07-15Lamb Scott EdirectorAward / grant2,40058,935Form 4
2026-07-15Nackel John G.directorAward / grant1,900174,565Form 4
2026-07-15SMITH BARRY MdirectorAward / grant1,900102,499Form 4
2026-07-15Snapper Suzanne D.directorAward / grant1,900230,364Form 4
2026-07-15Morris Gregory K Sr.directorAward / grant1,90037,300Form 4
2026-07-15COVEY STEPHEN M RdirectorAward / grant1,90044,050Form 4
2026-07-15Christensen Christopher R.directorAward / grant1,900145,991Form 4
2026-07-10Guerisoli BrentofficerOption exercise6,2480Form 4
2026-07-10Guerisoli BrentofficerOption exercise6,248106,988Form 4
2026-07-07Guerisoli BrentofficerOption exercise6,249103,905Form 4
2026-07-07Guerisoli BrentofficerOption exercise6,2496,248Form 4
2026-05-22Guerisoli BrentofficerOption exercise4,46399,910Form 4
2026-05-22Guerisoli BrentofficerOption exercise4,46397,701Form 4
2026-05-22Guerisoli BrentofficerOption exercise4,4634,463Form 4
2026-05-22Guerisoli BrentofficerOption exercise4,4630Form 4
2026-04-15Christensen Christopher R.directorAward / grant1,900144,091Form 4
2026-04-15Snapper Suzanne D.directorAward / grant1,900228,464Form 4
2026-04-15SMITH BARRY MdirectorAward / grant1,900100,599Form 4
2026-04-15COVEY STEPHEN M RdirectorAward / grant1,90042,150Form 4
2026-04-15Morris Gregory K Sr.directorAward / grant1,90035,400Form 4
2026-04-15Lamb Scott EdirectorAward / grant2,40056,535Form 4
2026-04-15Nackel John G.directorAward / grant1,900172,665Form 4
2026-03-05Guerisoli BrentofficerAward / grant45,00045,000Form 4
2026-03-05Gochnour John JofficerAward / grant41,00041,000Form 4
2026-03-05Walbom LynetteofficerAward / grant34,00034,000Form 4
2026-03-05Cheney Kirk SterlingofficerAward / grant30,00030,000Form 4
2026-03-05Steik Jason PaulofficerAward / grant26,00026,000Form 4
2026-03-03Cheney Kirk SterlingofficerAward / grant4,08521,005Form 4
2026-03-03Guerisoli BrentofficerAward / grant20,052102,030Form 4
2026-03-03Gochnour John JofficerAward / grant18,565152,815Form 4
2026-03-03Walbom LynetteofficerAward / grant14,29216,955Form 4
2026-01-15COVEY STEPHEN M RdirectorAward / grant1,90040,250Form 4
2026-01-15SMITH BARRY MdirectorAward / grant1,90098,699Form 4
2026-01-15Morris Gregory K Sr.directorAward / grant1,90033,500Form 4
2026-01-15Nackel John G.directorAward / grant1,900170,765Form 4
2026-01-15Snapper Suzanne D.directorAward / grant1,900226,564Form 4
2026-01-15Christensen Christopher R.directorAward / grant1,900142,191Form 4
2026-01-15Lamb Scott EdirectorAward / grant2,40054,135Form 4
2025-11-11Cheney Kirk SterlingofficerOption exercise3,80016,920Form 4
2025-11-11Cheney Kirk SterlingofficerOption exercise3,8004,200Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.